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Exposure to particulate matter (PM) from 
combustion processes contributes substantially 
to cardiovascular and pulmonary ill health 
and premature mortality globally (Brook 
2008; Salvi and Barnes 2009). PM represents 
highly complex mixtures with large variations 
in size, chemical composition, shape, sur-
face, reactivity, and charge, in both time and 
space, due to variable sources, atmospheric 
chemical reactions, and meteorological con-
ditions (Sioutas et al. 2005). Nevertheless, 
for exposure assessment for epidemiological 
association with health outcomes and regula-
tion, PM is usually only considered as mass 
defined by size cutoff at 2.5 and 10 μm in 
aerodynamic diameter (PM2.5 and PM10, 
respectively). These measures are often little 
affected by ultrafine particles (UFPs) from, 
for example, diesel engine emission because 
of their low mass, although UFPs are thought 
to have important health effects due to their 
high alveolar deposition, small size (≤ 0.1 μm 
in aerodynamic diameter), large surface area, 
and potential to translocate (Delfino et al. 
2005). Moreover, in epidemiological studies, 
exposure levels are often assigned crudely and 
groupwise according to air monitoring data 
and sources near the residence, because the 
modest individual risks require large numbers 
and long observation times to assess. Personal 
exposure can be assessed by portable monitors 
or carefully registered time–activity patterns 
in well-defined microenvironments of expo-
sure in small numbers of subjects (Zou et al. 
2009). However, the internal dose of PM 
also depends on breathing patterns and air-
way deposition, and cardiovascular and other 
systemic effects of PM require further translo-
cation of PM constituents or signaling mol-
ecules or cells from the airways (Mills et al. 
2009). Oxidative stress with inflammation 
is thought to be central in the mechanisms 
of action for both the pulmonary and extra-
pulmonary health effects of PM (Mills et al. 
2009; Risom et al. 2005). Thus, biomark-
ers of oxidative stress should serve as proxy 
measures of the true internal exposure to PM 
to compare potential health impacts of dif-
ferent sources in both small controlled expo-
sure settings and large population approaches. 
Oxidative modification of DNA and lipids 
are particularly relevant for cancer and cardio-
vascular disease where oxidative stress in the 
circulation is important (Mills et al 2009; 
Risom et al. 2005). Experimental studies in 
animals and cell cultures have consistently 
shown that combustion-related PM induces 
oxidative stress and DNA damage in relevant 
organs and cells (Møller et al. 2008a, 2010). 
In our experience the effects on biomarkers of 
oxidized DNA and lipids are observed within 
a lag period < 24 hr after the exposure to PM.
A number of studies of PM exposure 
in humans have applied biomarkers of oxi-
dative damage to DNA and lipids in the 
blood compartment or in terms of products 
excreted in urine or exhaled breath con-
densate (EBC), as outlined in Table 1. The 
biomarkers of oxidatively damaged DNA 
include 8-oxo-7,8-dihydroguanine (8-oxo-
Gua) or the corresponding deoxynucleoside 
8-oxo-7,8-dihydro-2´-deoxyguanosine (8-ox-
odG) measured in DNA and urine, the exo-
cyclic M1 adduct to guanine (M1dG), and 
lesions detected as sites in DNA sensitive 
to formamido  pyrimidine DNA glycosylase 
(FPG) and endonuclease III (ENDOIII). The 
biomarkers of lipid peroxidation (LPO) prod-
ucts include conjugated dienes (CDs), lipid 
hydroperoxides, malondialdehyde (MDA), 
thiobarbituric acid–reactive substances 
(TBARS), and F2-isoprostanes measured in 
EBC, plasma, serum, or urine. However, 
a systematic approach is required to evalu-
ate the validity of their use as biomarkers of 
biological effective dose in this context. We 
undertook a systematic review of the pub-
lished studies to assess the extent and con-
sistency of associations between exposure to 
combustion-related PM and the biomarkers 
of oxidative damage to DNA and lipids.
Materials and Methods
Studies included in meta-analysis. The pub-
lications were identified by searches in the 
PubMed, EMBASE, and Web of Science data-
bases, as well as reference lists in the identified 
papers [see Supplemental Material for the 
search strategy (doi:10.1289/ehp.0901725)]. 
We included studies that investigated meas-
ures of effects of environmental air pollu-
tion exposure. This encompassed studies of 
subjects who had been exposed at work to 
environmental air pollution (e.g., policemen 
exposed to traffic exhaust). We excluded 
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Ba c k g r o u n d: Air pollution is thought to exert health effects through oxidative stress, which causes 
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oB j e c t i v e: We determined whether levels of oxidatively damaged DNA and lipid peroxidation 
products in cells or bodily fluids from humans are useful biomarkers of biologically effective dose in 
studies of the health effects of exposure to particulate matter (PM) from combustion processes.
da t a s o u r c e s: We identified publications that reported estimated associations between environ-
mental exposure to PM and oxidative damage to DNA and lipids in PubMed and EMBASE. We 
also identified publications from reference lists and articles cited in the Web of Science.
da t a e x t r a c t i o n: For each study, we obtained information on the estimated effect size to calcu-
late the standardized mean difference (unitless) and determined the potential for errors in exposure 
assessment and analysis of each of the biomarkers, for total and stratified formal meta-analyses.
da t a synthesis: In the meta-analysis, the standardized mean differences (95% confidence interval) 
between exposed and unexposed subjects for oxidized DNA and lipids were 0.53 (0.29–0.76) and 
0.73 (0.18–1.28) in blood and 0.52 (0.22–0.82) and 0.49 (0.01–0.97) in urine, respectively. The 
standardized mean difference for oxidized lipids was 0.64 (0.07–1.21) in the airways. Restricting 
analyses to studies unlikely to have substantial biomarker or exposure measurement error, stud-
ies likely to have biomarker and/or exposure error, or studies likely to have both sources of 
error resulted in standardized mean differences of 0.55 (0.19–0.90), 0.66 (0.37–0.95), and 0.65 
(0.34–0.96), respectively.
co n c l u s i o n s: Exposure to combustion particles is consistenly associated with oxidatively damaged 
DNA and lipids in humans, suggesting that it is possible to use these measurements as biomarkers 
of biologically effective dose.
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studies on occupational exposures to air 
pollution, such as metal smelting or incin-
eration, because these are characterized by 
exposure to other air pollution components 
than those found in urban air. We searched 
for publications with reported data on LPO 
products and oxidatively damaged DNA by 
means of the biomarkers outlined in Table 
1 in airways, the blood compartment, and 
urine. Isolated leukocytes, lymphocytes, or 
mononuclear blood cells are all referred to 
as white blood cells (WBCs). We used the 
term “oxidized nucleobases” for the urinary 
excretion of 8-oxodG and 8-oxoGua because 
they are not measured in DNA. Tables 2–5 
summarize details of the included studies. The 
results from some of the studies have been 
reported in multiple publications; we discuss 
these as studies rather than as individual pub-
lications because they originated from the 
same   investigation.
We stratified the studies into three broad 
categories: controlled exposures, panel studies, 
and cross-sectional studies. Studies with con-
trolled exposure to air pollution PM are the 
most robust type of design as either crossover 
studies or parallel groups of subjects exposed 
to air pollution constituents or filtered air. 
In panel studies, samples are collected from 
the same individuals at different times of the 
year in order to exploit contrasts in exposure 
due to temporal changes. This study design 
minimizes the influence of interindividual 
variation because the subjects are their own 
controls. However, the design is vulnerable to 
confounding because other factors such as diet 
and sunlight show temporal (e.g., seasonal) 
variation, which can affect the value of the 
biomarker as shown, for instance, for DNA 
damage in WBCs detected by the comet assay 
(Møller and Loft 2006; Møller et al. 2002). 
In addition, the quality of the panel study 
depends on the exposure characterization; 
personal exposure characterization shows a 
closer association with biomarker levels than 
does exposure assessed from stationary moni-
toring stations (Sørensen et al. 2003a, 2003b, 
2003c; Vinzents et al. 2005). Cross-sectional 
studies have a less controlled design than do 
the panel studies because the exposure gradi-
ent is obtained by collecting samples from 
subjects from different geographical areas or 
occupations. The cross-sectional studies can 
have optimal exposure characterization, but 
confounding can be a problem because indi-
vidual factors such as lifestyle, including diet, 
may influence the biomarker and covary with 
the exposure. This problem typically arises, 
for instance, when policemen and office per-
sonal or subjects from rural and urban areas 
are being compared.
We critically analyzed the studies with 
special focus on suboptimal exposure assess-
ment and the quality of biomarkers. We 
referred to these problems as potential meas-
urement error in the exposure assessment and 
biomarkers because they can be regarded as 
systematic errors that may affect the validity. 
Figure 1 outlines the relationship between the 
measurement error in exposure assessment 
and biomarker. We should emphasize that 
specific studies included in our analysis may 
have other sources of bias, including selec-
tion bias and small numbers of observations, 
which can affect the estimated effect size in a 
particular study.
Measurement error in exposure assessment. 
The primary exposure assessment in our anal-
ysis is the mass concentration of particles as 
PM2.5 or PM10 or the number concentra-
tion of UFPs. The exposure characterization 
encompasses data obtained from stationary 
monitor stations and personal monitors. We 
regarded personal exposure to PM as the opti-
mal exposure assessment; for studies without 
PM measurements we regarded data on ambi-
ent gasses [nitrogen oxides (NOx), ozone (O3), 
or sulfur dioxide], polycyclic aromatic hydro-
carbons (PAHs), and benzene as indirect esti-
mates of PM exposure with greater potential 
for error. Similarly, the urinary excretion of 
metabolites of PAHs [e.g., 1-hydroxypyrene 
(1-HOP)] and benzene [S-phenylmercapturic 
acid (S-PMA) and trans,trans-muconic acid 
(tt-MA)] generated by their biotransformation 
are potentially biased estimates of the ambient 
concentration of PM, although they may be 
important biomarkers of internal dose of the 
parent compound. The measured PM showed 
the strongest association with the biomark-
ers of oxidized DNA and lipids in studies 
that measured the exposure as both PM and 
nitrogen dioxide (NO2), 1-HOP, S-PMA, 
and tt-MA (Avogbe et al. 2005; Bräuner et al. 
2007; Sørensen et al. 2003a, 2003b). We 
expect that the measurement error will be 
nondifferential, which usually biases effect 
estimates toward the null because they tend 
to obscure contrasts between the exposed and 
unexposed and those with or without the 
  outcome of interest.
Measurement error related to   biomarkers. 
The potential for biomarker measurement 
error originates from unspecific measure-
ments or analytic flaws due to poor assay 
conditions. For instance, sub  optimal assay 
procedures used to detect oxidatively dam-
aged DNA may cause spurious oxidation 
that increases the apparent level of DNA 
damage. The level of 8-oxodG in DNA 
from   unexposed mammals is approximately 
1 lesion/106 dG (deoxyguanosine); the 
European Standards Committee on Oxidative 
DNA Damage (2003a, 2003b; Gedik et al. 
Table 1. Summary of biomarkers of oxidatively damaged DNA, nucleobases, and LPO products used in 
studies of the effect of combustion particles.
Biomolecule Description Assays
Oxidatively damaged DNA or nucleobases
ENDOIII/FPG DNA base lesions detected by bacterial ENDOIII or FPG 
enzymes, representing mainly oxidized purine (including 
8-oxodG) and pyrimidine lesions, respectively
Comet assay
8-oxodG Major oxidation product in nuclear DNA; detection of 
8-oxodG in urine or plasma mainly originates from 
oxidation of deoxyguanosine triphosphate in the 
nucleotide pool
HPLC-ECD, 
LC-MS/MS, 
antibodies
8-oxoGua Major oxidation product in nuclear DNA; detection of 
8-oxoGua in urine or plasma is likely to arise from cleavage 
of the oxidized base from DNA by repair enzymes (e.g., 
OGG1)
HPLC-ECD, 
LC-MS/MS, 
antibodies
M1dG Exocyclic DNA damage formed by reactive carbonyl 
compounds released from oxidized lipids
LC-MS, 
antibodies
LPO products
CDs Breakdown products of fatty acids considered to represent 
an early stage of the LPO process
Spectrophotometry
Lipid hydroperoxides Reaction product between O2 and carbon radical in lipids Spectrophotometry
MDA/TBARS Breakdown carbonyl product of LPO; the reaction with 
thiobarbituric acid forms adducts that can be detected 
by spectrophotometry; prepurification of urine or plasma 
before the reaction with thiobarbituric acid can be 
considered as a specific measurement of LPO products, 
whereas the simple TBARS assay is highly unspecific
Spectrophotometry
F2-isoprostanes Products that arise mainly from oxidation of arachidonic 
acid in phospholipids, often referred to as 8-iso-PGF2α or 
15-F2t-isoprostanes
GC-MS, 
LC-MS/MS, 
antibodies
Abbreviations: 8-oxodG, 8-oxo-7,8-dihydro-2´-deoxyguanosine; 8-oxoGua, 8-oxo-7,8-dihydroguanine; CDs, conjugated 
dienes; ECD, electrochemical detection; ENDOIII, endonuclease III; FPG, formamidopyrimidine DNA glycosylase; 
GC-MS, gas chromatography–mass spectrometry; HPLC, high-performance liquid chromatography; LC-MS, liquid 
chromatography–mass spectrometry; LC-MS/MS, liquid chromatography with tandem mass spectrometry; LPO, lipid 
peroxidation; M1dG, exocyclic M1 adduct to guanine; MDA, malondialdehyde; OGG1, 8-oxoguanine DNA glycosylase; 
TBARS, thio  barbituric acid–reactive substances. For descriptions and critical assessments of the assays as biomarkers, 
see Griffiths et al. (2002) and Halliwell and Whiteman (2004).Møller and Loft
1128  v o l u m e  118 | n u m b e r 8 | August 2010  •  Environmental Health Perspectives
2005) recommended that publications that 
report levels of 8-oxodG above a threshold 
of 5 lesions/106 dG should be interpreted 
with caution. The comet assay detects DNA 
damage by migration of DNA in agarose gels, 
and the end points are usually reported as 
extent of migration, although they can be 
transformed to lesions per unaltered nucleo-
tides by calibration with ionizing radiation 
(Forchhammer et al. 2008; Møller et al. 
2004). The level of oxidatively damaged DNA 
measured by the comet assay in WBCs of 
humans is < 1 lesion/106 nucleotides (Møller 
2006). Oxidatively damaged DNA, nucleo-
bases, and LPO products can be measured 
by antibody-based methods, but artificially 
high background levels can occur because of 
unspecific binding of the antibodies to other 
biomolecules (Halliwell and Whiteman 2004; 
Møller et al. 2008b). The simple assay of 
TBARS and CDs has been seriously criticized 
and is not recommended for in vivo detec-
tion of LPO products, whereas improved 
methods using high-performance liquid chro-
matography (HPLC) purification steps are 
more reliable assays of TBARS (Halliwell 
and Whiteman 2004). We classified bio-
markers with suboptimal biochemical analy-
sis as follows: (1) simple spectrophotometric 
measurement of TBARS without a prepuri-
fication step; (2) simple assays for CDs and 
lipid hydroperoxides, (3) levels of 8-oxodG 
exceeding a threshold of 5 lesions/106 dG in 
the unexposed group, and (4) detection of 
oxidatively damaged DNA, nucleobases, or 
lipids by antibody-based methods without 
prepurification steps. We expect that the 
biomarker measurement error will result in 
reduced effect estimates for both nonspecific 
biomarkers and assays having low sensitivity 
or a high limit of detection.
Assessment of estimated effect size. The 
studies differ considerably in design, and the 
results are reported in ways and units that 
preclude direct comparison of the estimated 
effect size in the studies. Thus, we have esti-
mated the effect of exposure on biomarkers 
as standardized mean differences with 95% 
confidence intervals (CIs) between exposed 
subjects and referents in a random effects 
meta-analysis by means of Review Manager 
(RevMan; version 5.0; Nordic Cochrane 
Centre, Cochrane Collaboration 2008, 
København Ø, Denmark). The standardized 
Table 2. Summary of controlled exposure studies on exposure to air pollution PM from combustion processes.
Biomarker Subjects (n) Sex, age, smoking Exposure assessmenta
Potential  
measurement 
error Findings Study
8-oxodG (ELISA) 
F2-isoprostanes 
(LC-MS/MS)
Subjects with metabolic 
syndrome exposed to 
diesel exhaust or FA for 
2 hr (10)
MF
18–49 years
NS
PM2.5, 4.8 and 205 μg/m3
NO, 38.6 and 1,516 ppb
NO2, 15.5 and 25.5 ppb
Biomarker 
(8-oxodG)
No difference in urinary 
excretion
Allen et al. 
2009b
8-iso-PGF2 (ELISA) 
8-oxodG, 8-oxoGua 
(HPLC/GC-MS) 
FPG sites (comet)
MDA (HPLC-FD)
Healthy subjects exposed 
to wood smoke in a 
chamber for 4 hr (13)
MF
20–56 years
NS
PM2.5, 261 and 14–27 μg/m3
UFPs, 137,500 and 5,950  
particles/cm3
NO2, 10 and 8.5 ppb
Biomarker 
(8-iso-PGF2 )
Increased urinary excretion 
of 8-iso-PGF and MDA 
levels in EBC; unaltered 
FPG sites (WBCs) and 
8-oxodG and 8-oxoGua 
(urine)
Barregard 
et al. 2006, 
2008; 
Danielsen 
et al. 2008c
FPG sites (comet) Healthy subjects exposed 
in a chamber for 24 
hr (29)
MF
20–40 years
NS
Personal UFPs, 6,169–15,362 
particles/cm3 (non-FA), and 91–542 
particles/cm3 (FA)
NOx, 25.3 ppb (non-FA), 28.3 ppb (FA), 
11.6 ppb (back ground), and 59.5 ppb 
(busy street)
O3, 12.1 ppb (non-FA), 4.3 ppb (FA), 
30.1 ppb (back ground), and 19.5 ppb 
(busy street)
No Decreased levels in WBCs 
by exposure to FA
Bräuner et al. 
2007
8-iso-PGF2 (ELISA) Elderly subjects exposed 
in the homes (41)
MF
60–75 years
NS
Personal UFPs, 10,016 particles/cm3 
(non-FA) and 3,206 particles/cm3 (FA)
PM2.5, 12.6 (non-FA) and 4.7 μg/m3 (FA)
NO2, 20.0 (non-FA) and 20.0 μg/m3 (FA)
Biomarker Unaltered urinary excretion Bräuner et al. 
2008
8-Isoprostane (ELISA) Subjects with stable 
coronary heart disease 
(12) and controls (12) 
exposed to CAPs for 2 hr
M
54 ± 2 and 59 ± 2 years
NS
UFPs, 99,400 and zero particles/cm3
NOx, 7.2 and 6.3 ppb
SO2, 0.13 and 0.13 ppb
O3, 5.0 and 6.0 ppb
Biomarker Increased in EBC by CAPs 
exposure
Mills et al. 
2008
MDA (HPLC) Subjects exercising in 
location with low and 
high traffic intensity (12)
M
21± 2 years
NS
Personal UFPs, 252,290 and 7,382 
particles/cm3
No Increased after exercise at 
location with high exposure
Rundell et al. 
2008d
8-oxoGua (HPLC-ECD) Healthy subjects exposed 
to traffic exhaust at a 
street intersection for 
4 hr (3)
M
22–25 years
NS
None (49,000 cars/12 hr) Exposure Increased urinary excretion 
during the first 12 hr and 
24 hr after exposure; 
normalized levels at 36 and 
48 hr after the exposure
Suzuki et al. 
1995e
FPG sites (comet) Subjects bicycling in 
Copenhagen (15)
MF
25 ± 3 years
NS
Personal UFPs (32,400 and 13,400 
particles/cm3)
PM10, 23.5 μg/m3 (street) and 
16.9 μg/m3 (background)
NO2, 32.1 and 24.2 μg/m3 (street) and 
11.3 μg/m3 (background)
No Increased after cycling in 
the traffic compared with 
cycling in the laboratory
Vinzents et al. 
2005
Abbreviations: ECD, electrochemical detection; ELISA, enzyme-linked immunosorbent assay; FA, filtered air; FD, fluorescence detection; GC-MS, gas chromatography–mass spec-
trometry; LC-MS, liquid chromatography–mass spectrometry; LC-MS/MS, liquid chromatography with tandem mass spectrometry; M, male; MF, male and female; NO, nitric oxide; NS, 
nonsmoker; iso-PGF2, 8-iso-PGF2, 8-iso-prostaglandin F2; SO2, sulfur dioxide.
aThe values represent exposure assessment in the high-exposure and low-exposure group, respectively, unless stated otherwise by specific footnotes. bWe calculated the mean and 
SD from the mean difference and 95% CI assuming no missing data in the pair analysis. cWe calculated the net difference in MDA from preexposure values and baseline-adjusted the 
data according to the level of MDA in the group of subjects exposed to filtered air. The SD was calculated from 90% CI. dWe used the mean level of MDA from the exercises at the 
locations with low and high PM concentration. eThe data correspond to the mean of the whole exposure period (0–48 hr).Oxidized DNA and lipids as exposure biomarkers
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mean difference is the difference in means of 
groups divided by the pooled standard devia-
tion (SD). It is a measurement of estimated 
effect, which can be used in a meta-analysis 
when all studies assess the same outcome (level 
of oxidized biomolecules in this analysis), but 
it is measured in a variety of ways with differ-
ent scales. We assessed the estimated effect size 
in a random model meta-analysis because it 
incorporates heterogeneity among studies. The 
heterogeneity between studies was analyzed by 
tau squared, chi squared, and I2 tests; tests for 
subgroup differences were carried out using 
the chi-square test. We obtained means, SDs, 
and the number of subjects from the stud-
ies, or we calculated these values from data 
reported in the publications (see Tables 2–5). 
The variance was reported in different ways in 
the original publications; thus, our estimates 
of 95% CIs may be biased, but the central 
estimates (means) should not be. We calcu-
lated the mean and SD from regression analy-
ses for studies that modeled continuous data 
and defined the exposure gradient as equal to 
either the interquartile range (Kelishadi et al. 
2009; Liu et al. 2009a, 2009b) or a 10 μg/m3 
increase in PM (Liu et al. 2007). The inter-
quartile range in PM2.5 was in the same range 
as a 10-μg/m3 increase in PM2.5 in the stud-
ies carried out in Windsor, Ontario, Canada 
(Liu et al. 2007, 2009a, 2009b), whereas the 
interquartile range (66.5 μg/m3 measured as 
PM10) measured by Kelishadi et al. (2009) 
in Iran was substantially higher, which could 
reflect different sources of exposure or PM 
fraction. We calculated overall means and 
SD for studies that included more than one 
group of exposed subjects or investigated the 
same subjects under different exposure sce-
narios (Avogbe et al. 2005; De Coster et al. 
2008; Mills et al. 2008; Novotna et al. 2007; 
Rundell et al. 2008; Singh et al. 2007; Staessen 
et al. 2001; Sørensen et al. 2003a, 2003b). We 
assumed that the interquartile ranges would 
be equal to the SDs found in studies that used 
nonparametric analyses and reported variation 
as ranges (Chen et al. 2007; Romieu et al. 
2008; Sørensen et al. 2003a, 2003b).
Table 3. Summary of panel studies on exposure to air pollution PM from combustion processes.
Biomarker Subjects (n)
Sex, age, 
smoking Exposure assessmenta
Potential 
measurement error Findings Study
8-oxodG (ELISA) Students followed for 
3 months (76)
MF
18–25 years
NS
PM2.5, 12.7–59.5 μg/m3
PM10, 22.2–87.2 μg/m3
SO2, 2.8–39.4 ppb
NO2, 2.8–33.3 ppb
O3, 22.5–48.3 ppb (stationary 
monitoring stations)
Biomarker exposure Positive association between 8-oxodG in 
plasma and SO2 and O3; no association 
with PM2.5, PM10, and NO2
Chuang et al. 
2007
TBARS (FD) Subjects with diabetes 
mellitus (25) followed 
for 7 weeks
MF
28–63 years
NS
Personal PM10, 25.5 (9.8–133) 
μg/m3
Biomarker Positive association between PM10 
levels and TBARS in plasma
Liu et al.2007b
TBARS (FD) 
8-Isoprostanes 
(immunoassay)
Asthmatics (182) 
followed for 4 weeks
MF
9–14 years
NS
PM2.5, 2.7–14.3 μg/m3
SO2, 1.3–13.8 ppb
NO2, 12.3–27.0 ppb
O3, 7.5–21.0 ppm
Stationary monitoring
Biomarker exposure Positive association between TBARS 
in EBC and SO2, NO2 and PM2.5, 
but not with O3; the concentration 
of 8-isoprostanes in EBC was only 
associated with SO2 concentration
Liu et al. 2009ac
TBARS (SPM) 
8-Isoprostanes (ELISA)
Normal subjects living 
in Windsor, Ontario, 
Canada (29) followed 
for maximally 50 days
MF
64–96 years
NS
PM2.5, 6.3 (0.9–16.6) μg/m3 
(personal exposure) and 
15.3 (10.4–24.2) μg/m3 
(outdoor)
Biomarker No association with personal PM2.5 
exposure and LPO products in plasma; 
an association with outdoor PM2.5 and 
TBARS in a subset of subjects without 
doctor-diagnosed cardiovascular 
disease or who did not take diabetic 
medication
Liu et al. 2009bd
TBARS (SPM) 
CDs (SPM)
Medical doctors 
investigated 1 or 16 
weeks after arrival in 
Mexico City (21)
NR
27–32 years
NS
O3, 141 ppb (no report of 
the O3 level in original 
residence)
Biomarker exposure Increased TBARS in serum after the 
first week of the stay, normalized in 
samples obtained 16 weeks after
Medina-Navarro 
et al. 1997e
MDA (FD) Asthmatics (107) 
followed for 2–16 
weeks (average 
8 weeks)
MF
10 ± 2 years
NS
PM2.5, 27.4 (4.2–89.5) μg/m3
NO2, 35.3 (13.9–73.5) ppb
O3, 31.1 (9.8–60.7) ppb 
(stationary monitoring 
stations)
Biomarker exposure Positive association between ambient 
PM2.5 levels and MDA in EBC
Romieu et al. 
2008f
8-oxodG (HPLC-ECD)
FPG sites (comet)
MDA (HPLC)
Students living in 
Copenhagen, Denmark 
(50) followed for 
1 year
MF
20–33 years
NS
Personal PM2.5, 16.1 
(10–24.5) μg/m3
PM2.5, 9.2 (5.3–14.8 
μg/m3 (stationary monitoring 
stations)
No Correlation between personal exposure 
to PM2.5 and 8-oxodG in WBCs and 
MDA in plasma (only women); no 
correlation between PM2.5 and FPG 
sites in WBCs or 24-hr urinary excretion 
of 8-oxodG; no correlation between 
biomarkers and stationary (urban 
background) measurements of PM2.5
Sørensen et al. 
2003a, 2003bg
8-oxodG (ELISA) Security guards 
analyzed before and 
after a work shift (2) 
followed for 2 months
NR
18–20 years
NS
PM2.5, 243 (199–460) μg/m3 Biomarker Increased in urine after the work shift Wei et al. 2009h
Abbreviations: ECD, electrochemical detection; ELISA, enzyme-linked immunosorbent assay; FD, fluorescence detection; M, male; MF, male and female; NR, not reported; NS, non-
smoker; SO2, sulfur dioxide; SPM, spectrophotometry.
aThe values represent exposure assessment in the high-exposure and low-exposure group, respectively, unless stated otherwise by specific footnotes. bWe calculated means and SD 
from the regression analysis in the study, based on 10-μg/m3 increase in PM10 and a coefficient of variation of 100%. cWe calculated the mean level of LPO from TBARS and 8-isopros-
tanes, and the SD from the lower 95% CI assuming that it is similar to the 5th percentile and the coefficient of variation is the same in the exposed and reference group. dWe calculated 
data from the regression model reported in the original publication. The data correspond to the difference in LPO products from the interquartile range in personal PM2.5 exposure. We 
calculated the SD from the coefficient of variation of data reported as 5th and 95th percentile, assuming that it is equivalent to 95% CI, and the mean level of LPO products from data of 
TBARS and 8-isoprostanes. eWe calculated the mean level of LPO products from TBARS and CDs.fWe calculated data (means) by regression analysis assuming that the SD is the same 
as the interquartile range. gWe assumed that the SD and interquartile is the same value for the analysis of 8-oxodG and calculated the mean level of ENDOIII/FPG sites. hThe study 
encompassed samples from two subjects analyzed on 29 working days.Møller and Loft
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Results
Oxidative damage reported in controlled 
exposure studies. Table 2 summarizes stud-
ies on the association between air pollution 
exposure and oxidized DNA and lipids in 
controlled exposure studies. The number of 
subjects in these studies is rather low (3–41 
subjects; mean ± SD, 18 ± 12), which may 
be because carrying out controlled exposure 
on a large number of subjects is demanding. 
A study of air pollution exposure to UFPs in 
persons bicycling for approximately 90 min 
in a laboratory or on traffic-intense streets 
reported that the level of FPG sites in WBCs 
was associated with the number concentration 
of UFPs (Vinzents et al. 2005). A subsequent 
investigation by the same group had a similar 
correlation between particulate fractions with 
median particle sizes of 23 nm and 57 nm 
(consistent with semivolatile organic com-
pounds from diesel exhaust and carbona-
ceous soot emissions into the air of a busy 
street) and the level of FPG sites in WBCs 
(Bräuner et al. 2007). A subsequent study in 
elderly subjects showed a statistically non-
significant decrease in urinary excretion of the 
F2-isoprostane 8-iso-prostaglandin-F2 after a 
Table 4. Summary of cross-sectional studies on exposure to air pollution PM from combustion processes in humans in different occupations.
Biomarker Subjects (n) Sex, age, smoking Exposure assessmenta
Potential 
measurement error Findings Study
8-oxodG (HPLC-ECD) 
MDA (HPLC)
Bus drivers (107) MF
27–60 years
NS
1-HOP (urine) Exposure Bus drivers in the city center had 
higher levels of urinary 8-oxodG 
excretion than did bus drivers 
from the rural/suburban area; no 
clear differences between urinary 
excretions on working days and on 
days off observed; unaltered MDA in 
plasma between bus drivers in the 
city center and rural/suburban area
Autrup et al. 1999, 
Loft et al. 1999b
Lipid hydroperoxides 
(SPM)
Traffic officers 
and controls (32)
M
38–52 years
S/NS
None Biomarker 
exposure
No difference between exposed and 
controls
Bonina et al. 2008c
FPG sites (comet) Airport personnel 
(41) and controls 
(31)
NR
43 ± 9 years
S/NS
Stationary sampling of 
PAHs
Urinary 1-HOP (urine)
Exposure Higher level in WBCs of exposed 
subjects
Cavallo et al. 2006d
8-oxodG (ELISA) Taxi drivers (95) 
and controls (75)
M
40 ± 4 and 44 ± 7 years
S/NS
1-HOP (urine) Biomarker 
exposure
Highest level in urine of exposed 
subjects
Chuang et al. 2003
8-oxodG (HPLC-ECD) Taxi-motor 
drivers and rural 
controls (41)
M
36 ± 5 years
NS
Ambient (stationary) 
concentration of PAHs 
and benzene
Urinary excretion of 
S-PMA and 1-HOP
Biomarker 
exposure
Highest level in WBCs of exposed 
subjects (high background level of 
8-oxodG, 11.1 lesions/106 dG)
Ayi Fanou et al. 
2006
8-oxodG (ELISA) Highway toll 
workers and 
controls (74)
F
26 ± 6 and 27 ± 5 years
S/NS
Traffic intensity 
and urinary 1-HOP 
glucuronide excretion
Biomarker 
exposure
Highest level in urine of exposed 
subjects
Lai et al. 2005
ENDOIII/FPG sites 
(comet)
Policemen from 
Prague, Czech 
Republic (65)
M
31 and 35 years 
(median)
NS
PM2.5 (stationary 
monitoring data, 33 ± 
40 and 15 ± 9 μg/m3)
PAHs (personal 
exposure, 8.5 ± 9 and 
3.0 ± 3.4 ng/m3)
Exposure Highest level in WBCs of exposed 
subjects; positive correlation 
between PAH exposure and DNA 
damage in samples collected in 
January
Novotna et al. 2007e
FPG sites (comet) Subjects exposed 
to traffic (44) 
and controls (27)
MF
35–64 years
S/NS
None Exposure Statistically nonsignificant higher 
level in WBCs of exposed subjects
Palli et al. 2009
8-oxodG (ELISA) 
15-F2t-isoprostanes 
(immunoassay)
Bus drivers (50) 
and controls (50)
M
50 ± 10 and 51 ± 11 
years
NS
PM2.5 and PM10 
(stationary monitoring 
station) and PAHs 
(personal exposure)
PM2.5, 32.1 ± 8.1 and 
20.9 ± 6.8 μg/m3
PM10, 38.6 ± 8.2 and 
24.1 ± 6.5 μg/m3
Biomarker 
exposure
Highest levels in urine of exposed 
subjects
Rossner et al. 2007, 
2008a, 2008bf
8-oxodG (LC-MS/MS) 
M1dG (immunoslot blot)
Policemen, bus 
drivers, and 
controls (356)
M
34.1 ± 9 years
S/NS
Concentration of PAHs 
in personal PM2.5 
samples
Biomarker 
exposure
Policemen in Kosice, Slovakia, 
had higher levels of 8-oxodG 
in WBCs than did controls; no 
effect in policemen from Prague; 
8-oxodG levels were very high 
(i.e., 53.6 lesions/106 nucleotides, 
corresponding to 244 lesions/106 
dG); significantly higher levels of 
M1dG in exposed subjects in Sofia
Singh et al. 2007
Abbreviations: ECD, electrochemical detection; ELISA, enzyme-linked immunosorbent assay; F, female; LC-MS, liquid chromatography–mass spectrometry; LC-MS/MS, liquid chroma-
tography with tandem mass spectrometry; M, male; MF, male and female; NR, not reported; NS, nonsmoker; S, smoker; SPM, spectrophotometry.
aThe values represent exposure assessment in the high-exposure and low-exposure group, respectively, unless stated otherwise by specific footnotes.bWe used data from bus drivers 
on working days. cWe pooled means and SD from smokers and nonsmokers of controls and traffic officers at the sampling before the intervention with phytochemicals (day 0). dThe 
publication reports the mean level DNA damage without indication of the SD, whereas later studies by the same group showed a coefficient of variation of 40%. eThe data represent 
the variation between sampling in January and September. The personal exposure to PAHs in the exposed and control group was 6.0 and 4.5 ng/m3, respectively. fThe study had sam-
pling of PM2.5 and PM10 by personal monitors, but the low amount of material precluded the assessment of individual exposure.Oxidized DNA and lipids as exposure biomarkers
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Table 5. Summary of cross-sectional studies on exposure to air pollution PM from combustion processes in different areas.
Biomarker Subjects (n)
Sex, age, 
smoking Exposure assessmenta
Potential 
measurement 
error Findings Study
FPG sites (comet) Taxi-motor drivers, 
people living/working 
near busy roads and 
rural controls (135)
M
34 ± 10 years
NS
Ambient (stationary) sampling 
of UFPs (201,691 and 6,961 
particles/cm3) (midday 1-hr 
concentration in a busy street 
intersection and town square 
in a rural village, respectively) 
and urinary excretion of S-PMA
Exposure Association between S-PMA excretion 
and FPG sites in WBCs
Avogbe et al. 
2005
8-oxodG (HPLC-ECD) Children living in rural 
and urban area (75)
M
9–13 years
NS
Benzene (ambient monitoring 
and personal exposure)
Exposure Increased in WBCs and urine Buthbumrung 
et al. 2008
8-oxodG 
(immunohistochemistry)
Children living in a 
low-polluted area and 
Mexico City (98)
MF
6–13 years
NR
O3 (stationary monitoring data) Biomarker 
exposure
Higher level in nasal biopsies from 
children in Mexico City compared with 
children in the low polluted area
Calderón-
Garcidueñas 
et al. 1999
8-iso-PGF (ELISA) Subjects living in 
areas of high and low 
pollution (120)
MF
18–22 years
NS
PM10, 42.3 (25.7–67.9) and 25.6 
(17.8–28.6) ppb
NO2, 39.7 (8.3–49.9) and 21.6 
(11.4–29.6 ) ppb
O3, 42.9 (28.5–65.3) and 26.9 
(17.6–33.5) ppb (stationary 
monitoring stations with 
subsequent modeling)
Biomarker 
exposure
Highest level in plasma of subjects living 
in the most polluted area
Chen et al. 
2007b
8-oxodG (ELISA) Subjects living in 
Flanders, Belgium (399)
MF
50–65 years
S/NS
1-HOP (urine)
tt-MA (urine)
Biomarker 
exposure
Association between exposure 
biomarkers (1-HOP and tt-MA) and 
8-oxodG excretion in urine
De Coster 
et al. 2008c
TBARS (SPM) and CDs 
(SPM)
Medical doctors who 
lived in (24) or who 
recently moved to 
(21) Mexico City and 
controls (17)
NR
17–32 years
NS
O3, 152 and 29 ppb (stationary 
monitoring)
Biomarker 
exposure
No difference in serum level between 
subjects who had permanently or who 
had never lived in Mexico City; subjects 
who had recently (within one week) 
moved to Mexico City had elevated 
levels in serum
Hicks et al. 
1996d
TBARS (SPM) Subjects exposed to 
residential biomass 
smoke (28) and controls 
(15)
F
31–63 years
NS
None Biomarker 
exposure
Highest level in serum of exposed 
subjects
Isik et al. 2005
CDs 
MDA
Children living in 
Isfahan, Iran (374)
MF
10–18 years
NR
PM10, 122 ± 34 μg/m3 NO2, 
34 ± 13 ppbO3, 38 ± 12 ppb
SO2, 36 ± 14 ppb (stationary 
monitoring)
Biomarker 
exposure
Association between PM10 and CDs in 
plasma
Kelishadi et al. 
2009e
TBARS (SPM) Subjects living in rural 
(125) and urban (167) 
areas of Mexico
MF
34 ± 6 and 69 
± 8 years
NS
O3 (155 vs. 46 ppb) 
PM10 (122 vs. 104 μg/m3)
Stationary monitoring station
Biomarker 
exposure
Highest level in plasma of subjects living 
in Mexico City
Sanchez-
Rodriguez 
et al. 2005f
8-oxodG (HPLC-ECD) Subjects living in a rural 
village (100) and two 
suburbs of Antwerp, 
Belgium (100)
MF
17.2 ± 0.8 
years
S/NS
1-HOP (urine) 
tt-MA (urine)
Exposure Highest level in urine from exposed 
subjects; no correlations between 
exposure markers (1-HOP and tt-MA) 
and 8-oxodG excretion in urine
Staessen et al. 
2001g
8-oxodG (ELISA) Children living in areas 
of low and high air 
pollution exposure 
(894)
MF
6–11 years
NS
PM2.5, 22.7 and 16.8 μg/m3 
PM10, 30.0 and 20.4 μg/m3
Stationary monitoring station
Biomarker 
exposure
Positive association between air pollution 
exposure and urinary excretion of 
8-oxodG in the area with high air 
pollution (Teplice, Czech Republic); 
same association statistically 
nonsignificant in the area with low 
level of air pollution (Prachatice, Czech 
Republic)
Svecova et al. 
2009
ENDOIII/FPG sites 
(comet)
8-oxodG (HPLC-ECD)
Subjects living in 
Copenhagen, Denmark 
(40)
MF
36.5 (27–46 
years)
S/NS
Benzene (personal exposure and 
urinary S-PMA excretion)
Exposure Positive association between urinary 
S-PMA excretion and 8-oxodG (WBCs); 
no associations with ENDOIII/FPG sites 
(WBCs) or urinary excretion of 8-oxodG
Sørensen et al. 
2003ch
TBARS (SPM) Children living in 
Pancevo (industrial 
area) and Kovacica 
(village) in Serbia (128)
NR
12–15 years
NR
None Biomarker 
exposure
Highest level in plasma from exposed 
subjects
Vujovic et al. 
2009i
Abbreviations: CDs, conjugated dienes; ECD, electrochemical detection; ELISA, enzyme-linked immunosorbent assay; F, female; M, male; MF, male and female; NR, not reported; NS, 
nonsmoker; SPM, spectrophotometry; iso-PGF2, 8-iso-PGF2, 8-iso-prostaglandin F2; MDA, malondialdehyde; SO2, sulfur dioxide.
aThe values represent exposure assessment in the high-exposure and low-exposure group, respectively, unless stated otherwise by specific footnotes. bWe used the median and 
interquartile range as surrogates for the mean and SD. cWe used data from Antwerp, Belgium, and a rural area in the analysis because they had emissions of PAHs, and we estimated 
the SD from the 95% CI. dWe calculated the mean level of LPO products from TBARS and CDs. eWe used data based on the difference in interquartile range of the exposure (PM10) and 
assuming that the median concentration of exposure (122 μg/m3) corresponds to the mean level of MDA (0.7 μM) and CDs (2.5 μM). We calculated the SD from the mean coefficient of 
variation (11%) of the LPO products. fWe pooled mean and SD from adult and elderly subjects. gWe pooled data from Wilrijk and Hoboken, Belgium, for the analysis and calculated the 
SD from 95% CI. hWe used the mean and SD in the groups of subjects being either higher or lower than the median urinary excretion of S-PMA. iWe estimated the SD from 95% CI.Møller and Loft
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period of home air filtration (Bräuner et al. 
2008). In another study of elderly patients 
with coronary heart disease, Mills et al. (2008) 
reported that inhalation of concentrated air 
pollution particles (CAPs) was associated with 
increased concentration of 8-isoprostanes in 
EBC. This finding is in keeping with that 
found by Rundell et al. 2008) who observed 
that healthy young subjects had elevated level 
of MDA in EBC after intensive exercise at a 
location with high-traffic intensity compared 
with the same type of exercise at a location 
with less traffic.
Controlled exposure to wood smoke 
containing very high mass concentration of 
particles has been associated with increased 
levels of LPO products in serum, urine, 
and EBC (Barregard et al. 2006, 2008). 
However, Danielsen et al. (2008) observed 
no association between exposure and FPG 
sites in WBCs and suggested that this result 
may be due to increased DNA repair activ-
ity of oxidized nucleobases because urinary 
excretion of 8-oxoGua and WBC expression 
levels of the 8-oxoguanine DNA glycosylase 
(OGG1) base excision repair enzyme, which 
removes 8-oxoGua from DNA, were increased 
after exposure to wood smoke but not after 
exposure of the same subjects to clean air. 
Increased urinary excretion of 8-oxoGua was 
also observed in a study where subjects were 
exposed to exhaust on a traffic-intense street 
for 4 hr (Suzuki et al. 1995), but 2 hr of expo-
sure to a high concentration of diesel exhaust 
was not associated with urinary excretion of 
8-oxodG or F2-isoprostanes in subjects with 
metabolic syndrome (Allen et al. 2009).
Oxidative damage reported in panel stud-
ies. Table 3 summarizes studies on the asso-
ciation between air pollution exposure and 
oxidized DNA and lipids in panel studies. 
These studies involved multiple measurements 
over time, and the number of subjects in 
these studies was higher than the number of 
subjects in controlled exposure studies (2–182 
subjects; mean ± SD, 62 ± 59). Several panel 
studies showed that concurrent air pollution 
exposure was associated with elevated levels 
of LPO products in EBC (Liu et al. 2009a; 
Romieu et al. 2008) and plasma (Liu et al. 
2007; Medina-Navarro et al. 1997), as well as 
elevated levels of 8-oxodG in plasma (Chuang 
et al. 2007). Subjects without doctor-diag-
nosed cardiovascular diseases or who did not 
take medication for diabetes showed an asso-
ciation between outdoor levels of PM2.5 and 
TBARS in plasma, although the analysis of 
all subjects in the study only indicated sta-
tistically nonsignificant associations between 
personal exposure to PM2.5 and TBARS or 
8-isoprostanes in plasma (Liu et al. 2009b). 
Personal exposure to PM2.5 was associated 
with increased levels of 8-oxodG in WBCs of 
students living in the center of Copenhagen, 
whereas the exposure was only associated 
with the MDA levels of women and not with 
the level of FPG sites in WBCs in any group 
(Sørensen et al. 2003a, 2003b). Interestingly, 
Sørensen et al. (2003a, 2003b) observed no 
correlation between 8-oxodG in WBCs and 
the background mass concentration of PM2.5 
measured at stationary monitoring stations, 
suggesting that a relatively clean urban air 
may provide too little contrast in the long-
range transported fractions of PM to be a reli-
able indicator of traffic-generated exposure. 
Moreover, they found significant association 
between the biomarkers and personal expo-
sure to NO2 supporting the key role of PM. 
This is in keeping with observations from a 
controlled exposure study with constant NO2 
exposure, which showed a strong effect of 
change in PM exposure on DNA oxidation 
(Bräuner et al. 2007).
Oxidative damage reported in cross-
  sectional studies. The design of the cross-
  sectional studies can be grouped into two main 
categories. The first category is characterized 
by studies that achieved the exposure contrast 
by studying subjects in occupations with dif-
ferent ambient air pollution levels (Table 4). 
The other category is characterized by studies 
of subjects, often with comparable occupations 
or ages, from geographical areas with different 
ambient air pollution levels (Table 5). The 
cross-sectional studies have generally included 
more subjects than the controlled exposure 
studies and panel studies. The number of sub-
jects in the cross-sectional studies on different 
occupations has been in the range of 31–356 
subjects (mean ± SD = 109 ± 95 subjects), 
whereas the studies that have contrasted expo-
sure in different geographical areas have used 
even higher number of subjects (43–894 sub-
jects; mean ± SD = 222 ± 234).
Using job titles as the basis for stratifica-
tion of exposure, studies showed that sub-
jects in occupations with high exposure to 
traffic emissions had higher levels of FPG 
sites (Avogbe et al. 2005; Cavallo et al. 2006; 
Palli et al. 2009) and 8-oxodG and M1dG 
(Ayi Fanou et al. 2006; Singh et al. 2007) in 
WBCs than did referents. However, the latter 
two studies reported levels of 8-oxodG that 
were above the threshold of 5 lesions/106 dG, 
suggesting the potential for spurious oxidation 
of the samples. Another study showed higher 
levels of FPG and ENDOIII sites in WBCs of 
traffic emission exposed policemen compared 
with other policemen working indoor during 
a month when air pollution was relatively 
high (i.e., January) but no association during 
a month with low air pollution exposure (i.e., 
September) (Novotna et al. 2007). In con-
trast, Bonina et al. (2008) found no difference 
in serum lipid hydroperoxides concentration 
when comparing traffic officers with healthy 
indoor workers; the primary purpose of their 
study appears to have been to compare lipid 
hydroperoxide levels between subjects that 
received phytochemicals and subjects that did 
not, and they evaluated associations with air 
pollution in a secondary analysis. Evidence 
of null associations in studies that evaluate air 
pollution as a secondary exposure suggests the 
possibly of a general trend toward publica-
tion bias favoring studies that report positive 
associations when air pollution is the primary 
exposure of interest, but the findings of the 
Bonina et al. (2008) study may also have 
been due to the use of a nonspecific spectro-
photometric assay for the detection of LPO 
products, which can bias the estimated effect 
toward null. Studies using urinary biomarkers 
have also shown increased levels of 8-oxodG 
and 15-F2t-isoprostanes in subjects exposed to 
high concentrations of traffic-vehicle exhausts 
(Chuang et al. 2003; Lai et al. 2005; Rossner 
et al. 2008a, 2008b).
Cross-sectional studies of subjects living, 
working, or going to school in locations with 
different ambient air pollution levels encom-
pass investigations of subjects with predefined 
age groups, such as children, adolescents, 
adults, or elderly. Studies of children living 
in areas with different levels of exposure have 
shown positive associations with 8-oxodG lev-
els in nasal cells (Calderón-Garcidueñas et al. 
1999), 8-oxodG in WBCs (Buthbumrung 
et al. 2008), LPO products in plasma 
(Kelishadi et al. 2009; Vujovic et al. 2009), 
and urinary excretion of 8-oxodG (Svecova 
et al. 2009). Studies of air pollution exposure 
in adults have provided more mixed results: 
benzene as a marker of urban air pollution 
exposure was associated with urinary excre-
tion of S-PMA and 8-oxodG in WBCs, but 
not with ENDOIII and FPG sites in WBCs 
or urinary excretion of 8-oxodG (Sørensen 
et al. 2003c). Other studies of urinary excre-
tion of 8-oxodG have shown positive asso-
ciations (De Coster et al. 2008; Loft et al. 
Figure 1. Types of errors in studies of the effect of 
combustion air pollution. oxDNA, oxidatively dam-
aged DNA.
Gases, PAH
benzene, 1-HOP
Assay 
speciﬁcity
Estimated effect 
(oxDNA/LPO)
Exposure 
(PM)
Season (panel study)
Diet (cross-sectional study)
Exposure
assessment
error
Confounding
Outcome
measurement
errorOxidized DNA and lipids as exposure biomarkers
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1999; Staessen et al. 2001; Wei et al. 2009), 
but studies of LPO products in plasma have 
indicated both positive associations with oxi-
dative damage (Chen et al. 2007; Isik et al. 
2005; Sanchez-Rodriguez et al. 2005) and no 
apparent effects (Autrup et al. 1999; Hicks 
et al. 1996).
Combined effect estimates for markers in 
airways, blood, and urine. The qualitative 
assessment in the preceding sections indicates 
that most of the reports showed associations 
between air pollution exposure and oxidatively 
damaged DNA, nucleobases, and lipids. Most 
studies measured the biomarkers in surro-
gate tissue cells such as WBCs or noncellular 
bodily fluids such as plasma, urine, and EBC. 
The data on biomarkers of the airways mainly 
encompass measurements of LPO products 
in EBC, whereas only one study examined 
8-oxodG in nasal cells (Calderón-Garcidueñas 
et al. 1999). Figure 2 shows study-specific and 
overall estimates of effect for exposure to PM 
on oxidatively damaged DNA, nucleobases, 
and lipids in the airways, blood, and urine. 
In general there is considerable heterogeneity 
between the studies and between subgroups; 
methodological diversity between studies may 
explain the heterogeneity. In addition, the 
cate  gorization of the exposure does not take 
into account that exposure gradients most 
likely differ between the studies. It is not pos-
sible to calculate a standardized exposure unit 
(e.g., effect per 10-μg/m3 increase PM2.5) 
because the studies reported exposure mea-
surements in different fractions of PM, or 
they contained no information about the con-
centration of PM. The overall standardized 
mean differences between exposed subjects 
and nonexposed referents for the oxidized 
DNA and for LPO products in the blood 
were 0.53 (95% CI, 0.29–0.76) and 0.73 
(95% CI, 0.18–1.28), respectively. In the 
urine the estimated effect size by PM exposure 
versus nonexposed referents for oxidatively 
damaged DNA and nucleobases and for LPO 
products was 0.52 (95% CI, 0.22–0.82) and 
0.49 (95% CI, 0.01–0.97), respectively. This 
suggests that exposure to PM is associated 
with comparable increases in oxidized DNA 
and lipids, although it should be emphasized 
that the heterogeneity between subgroups 
might mask real differences between the bio-
markers. The effect on DNA damage in the 
airways is presently difficult to assess because 
there was only one study of oxidized DNA 
(Calderón-Garcidueñas et al. 1999). The esti-
mated effect on LPO products in EBC was 
0.64 (95% CI, 0.07–1.21), which is compa-
rable to overall standardized mean differences 
in LPO products in the blood and urine with 
PM exposure. This finding suggests that LPO 
products in plasma and urine are suitable 
biomarkers of biologically effective PM dose 
reflecting oxidative stress in the airways.
Combined estimates according to the 
potential for exposure or outcome measure-
ment error. The focus of our analysis was on 
the estimated effect of exposure to PM on bio-
markers of oxidized DNA, nucleobases, and 
lipids. A number of studies have not meas-
ured personal exposure to PM, which may be 
because of their focus on other air pollution 
constituents or lack of resources or because 
the study was too large to do personal expo-
sure measurements. Ideally, all studies should 
have included personal meas  urements of PM, 
and the analysis should have included mutual 
adjustment for coexposures to other air pollut-
ants. We assumed that PM is the most impor-
tant contributor to oxidative stress among the 
air pollutants and that personal exposure can 
be estimated from the personal exposure to 
the other pollutants or ambient PM levels, 
although with potential bias. Of the studies 
identified in our meta-analysis, only Chen 
et al. (2007) has estimated personal exposure 
levels using mathematical modeling of data 
from stationary monitoring stations. We have 
categorized the studies according to whether 
or not they characterized exposure using 
personal versus ambient PM measurements. 
Based on the categorization of the stud-
ies according to the potential measurement 
error in Tables 2–5, the estimated effect size 
is 0.55 (95% CI, 0.19–0.90), 0.66 (95% CI, 
0.37–0.95), and 0.65 (95% CI, 0.34–0.96) 
for studies categorized as having no potential 
measurement error, potential measurement 
error in either biomarker analysis or expo-
sure assessment, and potential measurement 
error in both biomarker analysis or exposure 
assessment, respectively [see Supplemental 
Material for the Forest plots (doi:10.1289/
ehp.0901725)]. The effect size is essentially 
identical in the three groups, which could be 
caused by opposite acting effects of potential 
measurement errors (regression toward null 
effect) and uncontrolled confounding fac-
tors (increased effect size) in panel and cross-
sectional studies. The percentages of studies 
that did not use personal measurements to 
assess PM exposure were 8% (1 of 12), 36% 
(4 of 11), and 100% (29 of 29) in the stud-
ies categorized as controlled exposures, panel 
studies, and cross-sectional studies, respec-
tively (χ2 = 36.7, p < 0.001). The use of 
error-prone biomarker assays was less likely 
in the controlled exposure studies (31%; 4 of 
13) than in the panel studies (64%; 7 of 11) 
and cross-sectional studies (59%; 17 of 29), 
although no differences were found between 
the distributions (χ2 = 3.4, p > 0.05). Overall, 
the quality of the studies, in terms of the like-
lihood of exposure and outcome measure-
ment error, appears highest in the controlled 
studies and lowest in the cross-sectional stud-
ies. Both of these measurement errors may 
bias the effect estimate toward null, whereas 
uncontrolled confounding factors in panel 
studies and cross-sectional studies most likely 
increased the estimated effect size. In addi-
tion, we emphasize that the studies that meas-
ured personal PM exposure and used more 
accurate biomarker assays mainly investigated 
the effect of air pollution particles in realistic 
urban air concentrations (Bräuner et al. 2007, 
2008; Rundell et al. 2008; Sørensen et al. 
2003a, 2003b; Vinzents et al. 2005), although 
one study used high concentrations of wood 
smoke particles (Barregard et al. 2006, 2008; 
Danielsen et al. 2008). Collectively, associa-
tions between PM exposure and biomarkers 
of oxidative stress estimated by studies likely 
to have more accurate exposure and outcome 
measurements cannot be explained by expo-
sure to excessive concentrations of PM. Yet, 
the controlled exposure studies in our meta-
analysis had few numbers of observations, 
which might reduce the precision with which 
effects have been estimated. In addition, con-
trolled exposure studies may be more prone to 
selection bias due to random errors in selec-
tion and have limited generalizability because 
they are restricted to participants with specific 
characteristics.
Discussion
Our analysis shows that exposure to combus-
tion particles is consistently associated with 
elevated levels of oxidatively damaged DNA 
and nucleobases and LPO products in human 
blood cells, plasma, urine, and EBC. The 
association is seen across studies with opti-
mum designs, including controlled or personal 
exposure assessment and biomarkers with low 
potential measurement error due to indirect 
exposure assessment and/or use of biomarkers 
prone to artifacts. Still, we emphasize that the 
identified studies are inhomogeneous in design 
and quality of biomarkers, which weakens our 
conclusions about specific exposure–effect 
relationships for particulate air pollution. In 
addition, few numbers of subjects, especially 
in the controlled exposure studies, is a minor 
limitation that might affect the generalizability 
of our meta-analysis results.
Our critical analysis indicates that the 
range in exposure to realistic ambient concen-
trations of combustion particles is associated 
with a 50% increase in the level of oxidatively 
damaged DNA, nucleobases, and lipids, sup-
porting the notion that they are suitable bio-
markers of the biologically effective dose of 
PM. However, we caution against the use of 
suboptimal biomarkers; ideal biomarkers of 
oxidative damage should detect a major part 
of the total ongoing oxidative damage in vivo, 
have small assay variation, have smaller 
intraindividual than interindividual variation, 
not be confounded by diet, be stable on stor-
age, and have the same level obtained in target 
and surrogate tissue (Halliwell and Whiteman Møller and Loft
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Figure 2. Forest plot of air pollution exposure on biomarkers of oxidized DNA, nucleobases, and lipids. Specific biomarkers in studies that have measured multiple 
assays of oxidized DNA and lipids are (1) 8-oxodG, (2) M1dG, (3) 8-oxodG, (4) ENDOIII/FPG sites, (5) ENDOIII/FPG sites, (6) 8-oxodG, (7) 8-oxodG, and (8) 8-oxoGua 
(the numbers in parentheses refer to references citations that are listed by first author/year only). 
Std. Mean Difference,
95% CI
–4 –2 0
Favors experimental Favors control
24
Airways/DNA damage           
Calderon-Garciduenas et al. 1999  602.0  195.0  87  210.0  122.0  12  1.8%  2.07 (1.40, 2.74)
Subtotal (95% CI)     87     12  1.8%  2.07 (1.40, 2.74)
Heterogeneity: Not applicable            
Test for overall effect: Z = 6.04 (p < 0.00001)
Airways/LPO products            
Barregaard et al. 2008  0.0053  0.0865  13  0.0  0.022  13  1.7%  0.08 (–0.69, 0.85)
Liu et al. 2009a  0.9  4.97  182  0.85  4.65  182  2.3%  0.01 (–0.20, 0.22)
Mills et al. 2008  16.6  7.6  8  4.5  1.3  8  1.1%  2.10 (0.81, 3.39)
Romieu et al. 2008  14.0  16.3  107  12.4  16.3  107  2.2%  0.10 (–0.17, 0.37)
Rundell et al. 2008  27.2  6.9  12  12.2  3.9  12  1.3%  2.58 (1.45, 3.72)
Subtotal (95% CI)     322     322  8.6%  0.64 (0.07, 1.21)
Heterogeneity: Tau² = 0.29; χ² = 28.40, df = 4 (p < 0.0001); I² = 86%            
Test for overall effect: Z = 2.21 (p = 0.03)            
Blood/DNA damage            
Avogbe et al. 2005  9.2  3.11  108  5.39  2.47  27  2.1%  1.26 (0.82, 1.71)
Braüner et al. 2007  0.53  0.28  29  0.38  0.22  29  2.0%  0.59 (0.06, 1.11)
Buthbumrung et al. 2008  0.25  0.13  40  0.08  0.34  32  2.0%  0.68 (0.20, 1.16)
Cavallo et al. 2006  12.85  5.14  41  7.97  3.19  31  2.0%  1.09 (0.59, 1.60)
Chuang et al. 2007  0.57  0.2  76  0.6  0.2  76  2.2%  –0.15 (–0.47, 0.17)
Danielsen et al. 2008  0.225  0.13  12  0.255  0.119  12  1.6%  –0.23 (–1.04, 0.57)
Fanou et al. 2006  2.02  1.25  35  1.11  0.82  6  1.5%  0.74 (–0.14, 1.62)
Novotna et al. 2007  2.52  1.73  54  1.29  1.21  11  1.8%  0.73 (0.07, 1.39)
Palli et al. 2008  5.0  3.06  44  4.11  3.96  27  2.0%  0.26 (–0.22, 0.74)
Singh et al. 2007 (1)  58.3  34.9  98  49.2  30.4  105  2.2%  0.28 (0.00, 0.55)
Singh et al. 2007 (2)  33.0  33.1  198  29.2  21.1  156  2.3%  0.13 (–0.08, 0.34)
Sørensen et al. 2003a (3)  1.51  6.8  49  0.5  3.5  49  2.1%  0.19 (–0.21, 0.58)
Sørensen et al. 2003a (4)  0.58  0.33  49  0.27  0.18  49  2.1%  1.16 (0.73, 1.59)
Sørensen et al. 2003c (5)  9.76  17.5  20  5.01  5.2  19  1.8%  0.36 (–0.28, 0.99)
Sørensen et al. 2003c (6)  1.03  1.07  14  0.376  0.66  14  1.7%  0.71 (–0.05, 1.48)
Vinzents et al. 2005  0.08  0.08  14  0.02  0.04  14  1.7%  0.92 (0.14, 1.71)
Subtotal (95% CI)     881     657  31.1%  0.53 (0.29, 0.76)
Heterogeneity: Tau² = 0.15; χ² = 61.54, df = 15 (p < 0.00001); I² = 76%            
Test for overall effect: Z = 4.42 (p < 0.00001)            
Blood/LPO products            
Autrup et al. 1999  0.87  0.19  55  0.96  0.25  45  2.1%  –0.41 (–0.81, –0.01)
Bonina et al. 2008  340.17  41.4  20  348.91  31.67  12  1.7%  –0.22 (–0.94, 0.49)
Chen et al. 2007  195.3  46.0  61  97.2  34.7  59  2.0%  2.39 (1.92, 2.86)
Hicks et al. 1996  5.05  1.55  24  5.23  0.9  17  1.9%  –0.13 (–0.76, 0.49)
Isik et al. 2005  3.28  0.79  28  1.47  0.63  15  1.6%  2.40 (1.58, 3.23)
Kelishadi et al. 2009  1.52  0.17  187  1.22  0.13  187  2.2%  1.98 (1.73, 2.23)
Liu et al. 2007  0.572  0.572  24  0.411  0.411  24  1.9%  0.32 (–0.25, 0.89)
Liu et al. 2009b  5.9  5.16  28  5.22  4.57  28  2.0%  0.14 (–0.39, 0.66)
Medina-Navarro et al. 1997  5.68  1.2  21  4.77  1.22  21  1.9%  0.74 (0.11, 1.37)
Sánches-Rodríguez et al. 2005  0.38  0.19  167  0.23  0.12  125  2.2%  0.91 (0.67, 1.16)
Sørensen et al. 2003b  35.9  7.4  47  36.3  8.0  47  2.1%  –0.05 (–0.46, 0.35)
Vujovic et al. 2009  1.25  0.43  42  0.99  0.32  82  2.1%  0.72 (0.33, 1.10)
Subtotal (95% CI)     704     662  23.8%  0.73 (0.18, 1.28)
Heterogeneity: Tau² = 0.88; χ² = 219.65, df = 11 (p < 0.00001); I² = 95%            
Test for overall effect: Z = 2.59 (p = 0.009)
Urine/Nucleobases           
Allen et al. 2009  0.087  0.193  6  0.0  0.193  6  1.2%  0.42 (–0.73, 1.57)
Buthbumrung et al. 2008  2.16  1.84  43  1.32  1.24  32  2.0%  0.52 (0.05, 0.98)
Chuang et al. 2003  13.4  4.7  95  11.5  4.7  75  2.2%  0.40 (0.10, 0.71)
Danielsen et al. 2008 (7)  8.43  6.48  10  4.24  2.31  10  1.5%  0.82 (–0.10, 1.75)
Danielsen et al. 2008 (8)  0.84  0.35  10  0.73  0.19  10  1.5%  0.37 (–0.51, 1.26)
De Coster et al. 2008  14.53  5.33  89  14.0  5.25  76  2.2%  0.10 (–0.21, 0.41)
Lai et al. 2005  13.3  7.1  47  8.4  6.2  24  2.0%  0.71 (0.21, 1.22)
Loft et al. 1999  190.0  108.0  29  146.0  89.0  27  2.0%  0.44 (–0.09, 0.97)
Rossner Jr et al. 2008a  6.66  2.41  50  5.21  2.23  50  2.1%  0.62 (0.22, 1.02)
Staessen et al. 2001  0.52  0.27  100  0.44  0.2  100  2.2%  0.34 (0.06, 0.61)
Suzuki et al. 1995  9.93  2.48  3  4.22  1.97  3  0.4%  2.04 (–0.50, 4.58)
Svecova et al. 2009  14.6  5.8  495  15.2  6.1  399  2.3%  –0.10 (–0.23, 0.03)
Sørensen et al. 2003a  0.23  0.14  49  0.122  0.09  49  2.1%  0.91 (0.49, 1.33)
Sørensen et al. 2003c  222.03  126.2  20  280.2  142.5  20  1.9%  –0.42 (–1.05, 0.20)
Wei et al. 2009  6.91  3.67  58  1.83  0.52  58  2.1%  1.93 (1.48, 2.37)
Subtotal (95% CI)     1104     939  27.7%  0.52 (0.22, 0.82)
Heterogeneity: Tau² = 0.26; χ² = 110.20, df = 14 (p < 0.00001); I² = 87%           
Test for overall effect: Z = 3.37 (p = 0.0007)        
Urine/LPO products           
Allen et al. 2009  0.0  0.234  6  0.05  0.234  6  1.3%  –0.20 (–1.33, 0.94)
Barregaard et al. 2006  0.036  0.051  11  0.016  0.018  11  1.6%  0.50 (–0.35, 1.35)
Bräuner et al. 2008  0.5  0.1  41  0.4  0.1  41  2.0%  0.99 (0.53, 1.45)
Rossner Jr et al. 2008b  0.77  0.27  50  0.68  0.38  50  2.1%  0.27 (–0.12, 0.66)
Subtotal (95% CI)     108     108  7.0%  0.49 (0.01, 0.97)
Heterogeneity: Tau² = 0.13; χ² = 7.09, df = 3 (p = 0.07); I² = 58%            
Test for overall effect: Z = 2.00 (p = 0.05)        
Total (95% CI)     3206     2700  100.0%  0.62 (0.43, 0.80)
Heterogeneity: Tau² = 0.40; χ² = 549.65, df = 52 (p < 0.00001); I² = 91%           
Test for overall effect: Z = 6.39 (p < 0.00001)            
Test for subgroup differences: χ² = 122.77, df = 5 (p < 0.00001), I² = 95.9%
  Experimental  Control  Std. Mean Difference,
Study or subgroup  Mean  SD  Total  Mean  SD  Total  Weight  95% CIOxidized DNA and lipids as exposure biomarkers
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2004). They should also have predictive value 
of risk of disease, which can be firmly assessed 
only in prospective studies (Loft and Møller 
2006). The biomarkers of urinary excretion 
of 8-oxodG and TBARS in plasma are among 
the few biomarkers that have been studied 
in prospective cohort studies; they have pre-
dictive value regarding development of lung 
cancer and cardiovascular diseases, respec-
tively (Loft et al. 2006; Walter et al. 2004). 
Further development of oxidized DNA and 
LPO products as biomarkers of biological 
effective dose of air pollution exposure should 
focus on the most reliable and well-validated 
assays, including assays for the measurement 
of isoprostanes and techniques that con-
sistently measure low background levels of 
oxidatively damaged DNA and nucleobases. 
The relevant biomarkers with low potential 
of measurement error are constantly devel-
oped to increase assay capacity toward high 
throughput, for instance, the comet assay and 
urinary excretion of 8-oxodG (Henriksen 
and Poulsen 2009; Stang and Witte 2009). 
This development will allow the use of these 
biomarkers of exposure to PM in large-scale 
population studies.
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